Comparison of Outcomes of Management of Bowel Obstruction
Launched by UNIVERSITY OF WASHINGTON · Jul 16, 2025
Trial Information
Current as of August 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called adhesive small bowel obstruction, which happens when scar tissue in the abdomen blocks the small intestine. The study is testing whether adding a medicine called dexamethasone, along with regular supportive care, helps patients recover without needing surgery, compared to supportive care alone. The goal is to see if dexamethasone can help more people get better safely without complications.
Adults 18 years and older who come to the hospital with this type of bowel blockage and do not need immediate surgery might be eligible to join. To participate, patients must have a diagnosis confirmed by a CT scan and symptoms showing the blockage is caused by scar tissue, not other problems like hernias or infections. If you join, you will receive either dexamethasone plus usual care or just usual care, and the doctors will monitor your recovery. The study is not yet recruiting, but it aims to find safer ways to treat this common condition without surgery when possible.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults ≥18 years of age recruited from UWMC
- • Patients presenting to surgical services through the Emergency Department, diagnosis of SBO, consulted by surgeon, and an urgent or emergency operation is deemed not necessary by surgeon.
- • Diagnosis of aSBO is established by;
- • 1. CT findings consistent with diagnosis of SBO; and
- • 2. signs and symptoms consistent with SBO; and
- • 3. Adhesions are the likely cause of SBO (absence of incarcerated hernia, internal hernia, masses, fistula, stricture, volvulus, acute episode of inflammatory bowel disease (IBD) flare, etc.).
- • Ability to provide written or electronic informed consent in English and answer teach-back questions
- Exclusion Criteria:
- • Signs and symptoms of peritonitis with emergency operation planned
- • Planned urgent operation within the next 12 hours
- • Allergy to dexamethasone
- • Surgery within prior 6 weeks
- • Unable or unwilling to return or be contacted for and/or complete research surveys
- • Currently incarcerated in a detention facility or in police custody (patients wearing a monitoring device can be enrolled) at baseline/screening
- • Individuals with latent infections who have an increased risk of infection.
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
David Flum, MD
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported